HEADER MEMBRANE PROTEIN 24-FEB-24 9AS3 TITLE LOCAL REFINEMENT OF 5-HT2AR BOUND TO LSD IN COMPLEX WITH A MINI-GQ TITLE 2 PROTEIN AND SCFV16 OBTAINED BY CRYO-ELECTRON MICROSCOPY (CRYOEM) COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5-HYDROXYTRYPTAMINE RECEPTOR 2A; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: 5-HT-2,5-HT-2A,SEROTONIN RECEPTOR 2A; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HTR2A, HTR2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS GPCR, G-PROTEIN COUPLED RECEPTOR, 5-HT2AR, SEROTONIN, PSYCHEDELICS, KEYWDS 2 MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR R.H.GUMPPER,J.F.FAY,B.L.ROTH REVDAT 2 04-JUN-25 9AS3 1 REMARK REVDAT 1 02-APR-25 9AS3 0 JRNL AUTH R.H.GUMPPER,M.K.JAIN,K.KIM,R.SUN,N.SUN,Z.XU,J.F.DIBERTO, JRNL AUTH 2 B.E.KRUMM,N.J.KAPOLKA,H.U.KANISKAN,D.E.NICHOLS,J.JIN, JRNL AUTH 3 J.F.FAY,B.L.ROTH JRNL TITL THE STRUCTURAL DIVERSITY OF PSYCHEDELIC DRUG ACTIONS JRNL TITL 2 REVEALED. JRNL REF NAT COMMUN V. 16 2734 2025 JRNL REFN ESSN 2041-1723 JRNL PMID 40108183 JRNL DOI 10.1038/S41467-025-57956-7 REMARK 2 REMARK 2 RESOLUTION. 3.18 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.180 REMARK 3 NUMBER OF PARTICLES : 168657 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9AS3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-FEB-24. REMARK 100 THE DEPOSITION ID IS D_1000281635. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : 5-HT2AR IN COMPLEX WITH MINI-GQ REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TALOS ARCTICA REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 160.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2600.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : OTHER REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4950.00 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 200 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 ILE A 3 REMARK 465 LEU A 4 REMARK 465 CYS A 5 REMARK 465 GLU A 6 REMARK 465 GLU A 7 REMARK 465 ASN A 8 REMARK 465 THR A 9 REMARK 465 SER A 10 REMARK 465 LEU A 11 REMARK 465 SER A 12 REMARK 465 SER A 13 REMARK 465 THR A 14 REMARK 465 THR A 15 REMARK 465 ASN A 16 REMARK 465 SER A 17 REMARK 465 LEU A 18 REMARK 465 MET A 19 REMARK 465 GLN A 20 REMARK 465 LEU A 21 REMARK 465 ASN A 22 REMARK 465 ASP A 23 REMARK 465 ASP A 24 REMARK 465 THR A 25 REMARK 465 ARG A 26 REMARK 465 LEU A 27 REMARK 465 TYR A 28 REMARK 465 SER A 29 REMARK 465 ASN A 30 REMARK 465 ASP A 31 REMARK 465 PHE A 32 REMARK 465 ASN A 33 REMARK 465 SER A 34 REMARK 465 GLY A 35 REMARK 465 GLU A 36 REMARK 465 ALA A 37 REMARK 465 ASN A 38 REMARK 465 THR A 39 REMARK 465 SER A 40 REMARK 465 ASP A 41 REMARK 465 ALA A 42 REMARK 465 PHE A 43 REMARK 465 ASN A 44 REMARK 465 TRP A 45 REMARK 465 THR A 46 REMARK 465 VAL A 47 REMARK 465 ASP A 48 REMARK 465 SER A 49 REMARK 465 GLU A 50 REMARK 465 ASN A 51 REMARK 465 ARG A 52 REMARK 465 THR A 53 REMARK 465 ASN A 54 REMARK 465 LEU A 55 REMARK 465 SER A 56 REMARK 465 CYS A 57 REMARK 465 GLU A 58 REMARK 465 GLY A 59 REMARK 465 CYS A 60 REMARK 465 LEU A 61 REMARK 465 SER A 62 REMARK 465 PRO A 63 REMARK 465 SER A 64 REMARK 465 CYS A 65 REMARK 465 LEU A 66 REMARK 465 SER A 67 REMARK 465 LEU A 68 REMARK 465 LEU A 69 REMARK 465 HIS A 70 REMARK 465 LEU A 71 REMARK 465 GLN A 72 REMARK 465 GLU A 73 REMARK 465 LYS A 74 REMARK 465 ASN A 75 REMARK 465 TRP A 76 REMARK 465 SER A 77 REMARK 465 ALA A 78 REMARK 465 LEU A 79 REMARK 465 LEU A 80 REMARK 465 THR A 81 REMARK 465 ALA A 82 REMARK 465 VAL A 83 REMARK 465 SER A 100 REMARK 465 LEU A 101 REMARK 465 GLU A 102 REMARK 465 LYS A 103 REMARK 465 LYS A 104 REMARK 465 LEU A 143 REMARK 465 PRO A 144 REMARK 465 LYS A 263 REMARK 465 GLU A 264 REMARK 465 ALA A 265 REMARK 465 THR A 266 REMARK 465 LEU A 267 REMARK 465 CYS A 268 REMARK 465 VAL A 269 REMARK 465 SER A 270 REMARK 465 ASP A 271 REMARK 465 LEU A 272 REMARK 465 GLY A 273 REMARK 465 THR A 274 REMARK 465 ARG A 275 REMARK 465 ALA A 276 REMARK 465 LYS A 277 REMARK 465 LEU A 278 REMARK 465 ALA A 279 REMARK 465 SER A 280 REMARK 465 PHE A 281 REMARK 465 SER A 282 REMARK 465 PHE A 283 REMARK 465 LEU A 284 REMARK 465 PRO A 285 REMARK 465 GLN A 286 REMARK 465 SER A 287 REMARK 465 SER A 288 REMARK 465 LEU A 289 REMARK 465 SER A 290 REMARK 465 SER A 291 REMARK 465 GLU A 292 REMARK 465 LYS A 293 REMARK 465 LEU A 294 REMARK 465 PHE A 295 REMARK 465 GLN A 296 REMARK 465 ARG A 297 REMARK 465 SER A 298 REMARK 465 ILE A 299 REMARK 465 HIS A 300 REMARK 465 ARG A 301 REMARK 465 GLU A 302 REMARK 465 PRO A 303 REMARK 465 GLY A 304 REMARK 465 SER A 305 REMARK 465 TYR A 306 REMARK 465 THR A 307 REMARK 465 GLY A 308 REMARK 465 ARG A 309 REMARK 465 ARG A 310 REMARK 465 THR A 311 REMARK 465 MET A 312 REMARK 465 GLN A 313 REMARK 465 SER A 314 REMARK 465 ILE A 348 REMARK 465 CYS A 349 REMARK 465 LYS A 350 REMARK 465 GLU A 351 REMARK 465 SER A 352 REMARK 465 CYS A 353 REMARK 465 TYR A 394 REMARK 465 ILE A 395 REMARK 465 GLN A 396 REMARK 465 CYS A 397 REMARK 465 GLN A 398 REMARK 465 TYR A 399 REMARK 465 LYS A 400 REMARK 465 GLU A 401 REMARK 465 ASN A 402 REMARK 465 LYS A 403 REMARK 465 LYS A 404 REMARK 465 PRO A 405 REMARK 465 LEU A 406 REMARK 465 GLN A 407 REMARK 465 LEU A 408 REMARK 465 ILE A 409 REMARK 465 LEU A 410 REMARK 465 VAL A 411 REMARK 465 ASN A 412 REMARK 465 THR A 413 REMARK 465 ILE A 414 REMARK 465 PRO A 415 REMARK 465 ALA A 416 REMARK 465 LEU A 417 REMARK 465 ALA A 418 REMARK 465 TYR A 419 REMARK 465 LYS A 420 REMARK 465 SER A 421 REMARK 465 SER A 422 REMARK 465 GLN A 423 REMARK 465 LEU A 424 REMARK 465 GLN A 425 REMARK 465 MET A 426 REMARK 465 GLY A 427 REMARK 465 GLN A 428 REMARK 465 LYS A 429 REMARK 465 LYS A 430 REMARK 465 ASN A 431 REMARK 465 SER A 432 REMARK 465 LYS A 433 REMARK 465 GLN A 434 REMARK 465 ASP A 435 REMARK 465 ALA A 436 REMARK 465 LYS A 437 REMARK 465 THR A 438 REMARK 465 THR A 439 REMARK 465 ASP A 440 REMARK 465 ASN A 441 REMARK 465 ASP A 442 REMARK 465 CYS A 443 REMARK 465 SER A 444 REMARK 465 MET A 445 REMARK 465 VAL A 446 REMARK 465 ALA A 447 REMARK 465 LEU A 448 REMARK 465 GLY A 449 REMARK 465 LYS A 450 REMARK 465 GLN A 451 REMARK 465 HIS A 452 REMARK 465 SER A 453 REMARK 465 GLU A 454 REMARK 465 GLU A 455 REMARK 465 ALA A 456 REMARK 465 SER A 457 REMARK 465 LYS A 458 REMARK 465 ASP A 459 REMARK 465 ASN A 460 REMARK 465 SER A 461 REMARK 465 ASP A 462 REMARK 465 GLY A 463 REMARK 465 VAL A 464 REMARK 465 ASN A 465 REMARK 465 GLU A 466 REMARK 465 LYS A 467 REMARK 465 VAL A 468 REMARK 465 SER A 469 REMARK 465 CYS A 470 REMARK 465 VAL A 471 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 140 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 185 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 187 CG OD1 ND2 REMARK 470 ARG A 189 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 213 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP A 218 CG OD1 OD2 REMARK 470 SER A 219 OG REMARK 470 LYS A 220 CG CD CE NZ REMARK 470 PHE A 222 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 223 CG CD CE NZ REMARK 470 ASP A 231 CG OD1 OD2 REMARK 470 ASP A 232 CG OD1 OD2 REMARK 470 ILE A 315 CG1 CG2 CD1 REMARK 470 GLN A 319 CG CD OE1 NE2 REMARK 470 ASN A 354 CG OD1 ND2 REMARK 470 GLU A 355 CG CD OE1 OE2 REMARK 470 ASP A 356 CG OD1 OD2 REMARK 470 SER A 392 OG REMARK 470 ARG A 393 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 139 -4.84 74.44 REMARK 500 SER A 219 -3.84 -140.79 REMARK 500 LYS A 220 -64.31 -90.05 REMARK 500 PHE A 222 -171.48 -171.71 REMARK 500 PHE A 243 -50.48 -121.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-43803 RELATED DB: EMDB REMARK 900 LOCAL REFINEMENT OF 5-HT2AR BOUND TO LSD IN COMPLEX WITH A MINI-GQ REMARK 900 PROTEIN AND SCFV16 OBTAINED BY CRYO-ELECTRON MICROSCOPY (CRYOEM) DBREF 9AS3 A 1 471 UNP P28223 5HT2A_HUMAN 1 471 SEQRES 1 A 471 MET ASP ILE LEU CYS GLU GLU ASN THR SER LEU SER SER SEQRES 2 A 471 THR THR ASN SER LEU MET GLN LEU ASN ASP ASP THR ARG SEQRES 3 A 471 LEU TYR SER ASN ASP PHE ASN SER GLY GLU ALA ASN THR SEQRES 4 A 471 SER ASP ALA PHE ASN TRP THR VAL ASP SER GLU ASN ARG SEQRES 5 A 471 THR ASN LEU SER CYS GLU GLY CYS LEU SER PRO SER CYS SEQRES 6 A 471 LEU SER LEU LEU HIS LEU GLN GLU LYS ASN TRP SER ALA SEQRES 7 A 471 LEU LEU THR ALA VAL VAL ILE ILE LEU THR ILE ALA GLY SEQRES 8 A 471 ASN ILE LEU VAL ILE MET ALA VAL SER LEU GLU LYS LYS SEQRES 9 A 471 LEU GLN ASN ALA THR ASN TYR PHE LEU MET SER LEU ALA SEQRES 10 A 471 ILE ALA ASP MET LEU LEU GLY PHE LEU VAL MET PRO VAL SEQRES 11 A 471 SER MET LEU THR ILE LEU TYR GLY TYR ARG TRP PRO LEU SEQRES 12 A 471 PRO SER LYS LEU CYS ALA VAL TRP ILE TYR LEU ASP VAL SEQRES 13 A 471 LEU PHE SER THR ALA SER ILE MET HIS LEU CYS ALA ILE SEQRES 14 A 471 SER LEU ASP ARG TYR VAL ALA ILE GLN ASN PRO ILE HIS SEQRES 15 A 471 HIS SER ARG PHE ASN SER ARG THR LYS ALA PHE LEU LYS SEQRES 16 A 471 ILE ILE ALA VAL TRP THR ILE SER VAL GLY ILE SER MET SEQRES 17 A 471 PRO ILE PRO VAL PHE GLY LEU GLN ASP ASP SER LYS VAL SEQRES 18 A 471 PHE LYS GLU GLY SER CYS LEU LEU ALA ASP ASP ASN PHE SEQRES 19 A 471 VAL LEU ILE GLY SER PHE VAL SER PHE PHE ILE PRO LEU SEQRES 20 A 471 THR ILE MET VAL ILE THR TYR PHE LEU THR ILE LYS SER SEQRES 21 A 471 LEU GLN LYS GLU ALA THR LEU CYS VAL SER ASP LEU GLY SEQRES 22 A 471 THR ARG ALA LYS LEU ALA SER PHE SER PHE LEU PRO GLN SEQRES 23 A 471 SER SER LEU SER SER GLU LYS LEU PHE GLN ARG SER ILE SEQRES 24 A 471 HIS ARG GLU PRO GLY SER TYR THR GLY ARG ARG THR MET SEQRES 25 A 471 GLN SER ILE SER ASN GLU GLN LYS ALA CYS LYS VAL LEU SEQRES 26 A 471 GLY ILE VAL PHE PHE LEU PHE VAL VAL MET TRP CYS PRO SEQRES 27 A 471 PHE PHE ILE THR ASN ILE MET ALA VAL ILE CYS LYS GLU SEQRES 28 A 471 SER CYS ASN GLU ASP VAL ILE GLY ALA LEU LEU ASN VAL SEQRES 29 A 471 PHE VAL TRP ILE GLY TYR LEU SER SER ALA VAL ASN PRO SEQRES 30 A 471 LEU VAL TYR THR LEU PHE ASN LYS THR TYR ARG SER ALA SEQRES 31 A 471 PHE SER ARG TYR ILE GLN CYS GLN TYR LYS GLU ASN LYS SEQRES 32 A 471 LYS PRO LEU GLN LEU ILE LEU VAL ASN THR ILE PRO ALA SEQRES 33 A 471 LEU ALA TYR LYS SER SER GLN LEU GLN MET GLY GLN LYS SEQRES 34 A 471 LYS ASN SER LYS GLN ASP ALA LYS THR THR ASP ASN ASP SEQRES 35 A 471 CYS SER MET VAL ALA LEU GLY LYS GLN HIS SER GLU GLU SEQRES 36 A 471 ALA SER LYS ASP ASN SER ASP GLY VAL ASN GLU LYS VAL SEQRES 37 A 471 SER CYS VAL HET 7LD A 501 24 HETNAM 7LD (8ALPHA)-N,N-DIETHYL-6-METHYL-9,10-DIDEHYDROERGOLINE-8- HETNAM 2 7LD CARBOXAMIDE HETSYN 7LD LYSERGIC ACID DIETHYLAMIDE FORMUL 2 7LD C20 H25 N3 O HELIX 1 AA1 VAL A 84 VAL A 99 1 16 HELIX 2 AA2 THR A 109 LEU A 122 1 14 HELIX 3 AA3 VAL A 127 TYR A 137 1 11 HELIX 4 AA4 LEU A 147 ASN A 179 1 33 HELIX 5 AA5 ASN A 179 PHE A 186 1 8 HELIX 6 AA6 THR A 190 SER A 207 1 18 HELIX 7 AA7 MET A 208 PHE A 213 1 6 HELIX 8 AA8 ASN A 233 SER A 239 1 7 HELIX 9 AA9 PHE A 243 LEU A 261 1 19 HELIX 10 AB1 SER A 316 VAL A 347 1 32 HELIX 11 AB2 GLU A 355 LEU A 382 1 28 HELIX 12 AB3 ASN A 384 ARG A 393 1 10 SSBOND 1 CYS A 148 CYS A 227 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 CONECT 442 1027 CONECT 1027 442 CONECT 1868 1874 1884 CONECT 1869 1878 1888 1890 CONECT 1870 1871 1884 CONECT 1871 1870 1885 CONECT 1872 1883 1885 1886 CONECT 1873 1874 1877 1883 CONECT 1874 1868 1873 CONECT 1875 1886 1887 CONECT 1876 1880 1887 CONECT 1877 1873 1882 CONECT 1878 1869 1891 CONECT 1879 1890 CONECT 1880 1876 1881 1882 CONECT 1881 1880 CONECT 1882 1877 1880 1886 CONECT 1883 1872 1873 1884 CONECT 1884 1868 1870 1883 CONECT 1885 1871 1872 CONECT 1886 1872 1875 1882 CONECT 1887 1875 1876 1888 CONECT 1888 1869 1887 1889 CONECT 1889 1888 CONECT 1890 1869 1879 CONECT 1891 1878 MASTER 378 0 1 12 0 0 0 6 1890 1 26 37 END